Physician profile
Aimee Caillet
NPI 1518378538
$5,162.95
in general payments reported to CMS, 2019-2025
40 companies · $1,590 in 2025
The $1,590 reported for 2025 was more than what 98% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $147 · 2021: $482 · 2022: $1,123 · 2023: $891 · 2024: $806 · 2025: $1,590.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,286.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,286.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $767.70 | 2019-2025 | Lupron Depot |
| Genzyme Corporation | $749.65 | 2022-2025 | |
| Qol Medical, LLC | $590.20 | 2020-2025 | Sucraid, Sucraid |
| Regeneron Healthcare Solutions, INC. | $439.72 | 2023-2025 | Dupixent, Evkeeza |
| Mirum Pharmaceuticals, INC. | $361.20 | 2022-2025 | Livmarli, Cholbam, Chenodal |
| Takeda Pharmaceuticals U.S.A., INC. | $228.38 | 2022-2025 | Eohilia, Gattex |
| Ipsen Biopharmaceuticals, INC | $202.13 | 2025 | Bylvay, Iqirvo |
| Ultragenyx Pharmaceutical INC. | $192.04 | 2021-2023 | |
| Mallinckrodt Hospital Products INC. | $170.47 | 2022-2025 | Acthar |
| Alexion Pharmaceuticals, INC. | $164.27 | 2021-2025 | Strensiq, Ultomiris |
| Azurity Pharmaceuticals, INC. | $158.47 | 2023-2025 | Triptodur, Triptodur, Xatmep |
| Dexcom, INC. | $149.18 | 2021-2025 | Dexcom G6 Transmitter |
| Xeris Pharmaceuticals, INC. | $143.96 | 2021-2024 | Gvoke Hypopen |
| Alcresta Therapeutics, INC. | $117.57 | 2023-2024 | Relizorb |
| Arbor Pharmaceuticals, INC. | $71.56 | 2021-2022 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aimee Caillet listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.